Associate, Life Sciences

About General Atlantic General Atlantic is a leading global investor with more than four and a half decades of experience providing capital and strategic support for over 885 companies throughout its history. Established in 1980, General Atlantic continues to be a dedicated partner to visionary founders and investors seeking to build dynamic businesses and create lasting value. Guided by the conviction that entrepreneurs can be incredible agents of transformational change, the firm combines a collaborative global approach, sector specific expertise, a long-term investment horizon, and a deep understanding of growth drivers to partner with and scale innovative businesses around the world. The firm leverages its patient capital, operational expertise, and global platform to support a diversified investment platform spanning Growth Equity, Infrastructure, and Strategic Solutions. General Atlantic manages approximately $126 billion in assets under management, inclusive of all strategies, as of March 31, 2026, with more than 900 professionals in 20 countries across five regions. For more information on General Atlantic, please visit www.generalatlantic.com. General Atlantic Life Sciences Practice The GA Life Sciences practice provides capital and strategic support for development stage biopharma companies, with an established track record across public and private investments. The Life Sciences team focuses on novel therapies that provide substantial patient benefit and have the potential to redefine standards of care. GA’s differentiated approach to life sciences is characterized by highly thematic investing, scaling significant capital into companies as they advance through clinical development and commercialization, and partnering with management teams to generate value. Investments include Akero Therapeutics (acquired by Novo Nordisk), Karuna Therapeutics (acquired by BMS), Cincor Pharma (acquired by AstraZeneca), and Centessa Pharmaceuticals (potential acquisition by Eli Lilly). Position Summary General Atlantic is seeking a Life Sciences investor to join our New York‑based investment team. This role will have exposure to all parts of the investment process, including evaluating new investment opportunities and investment themes in biopharma and life science companies, conducting technical diligence, supporting deal execution, and working with portfolio companies. The ideal candidate will have a scientific background (MD or PhD) and at least two years of relevant industry experience, with the goal of driving strategic growth and generating value for the firm’s portfolio. Responsibilities • Source, evaluate, and recommend investment opportunities in drug development / biopharmaceutical companies including development and ownership of thematic focus areas • Support scientific and clinical due diligence, integrating preclinical data, clinical trial results, regulatory strategy, and market dynamics into investment recommendations • Develop and present rigorous investment theses to senior stakeholders, including the global Investment Committee • Contribute across the full deal process, including coordination of third-party scientific advisors, KOLs, and commercial consultants • Monitor portfolio companies and support the GA team’s efforts in capital allocation and value creation • Leverage clinical and industry networks to generate proprietary deal flow and market intelligence • Collaborate with professionals across the firm and foster exceptional knowledge-sharing Qualifications • MD or PhD in relevant scientific field (molecular biology, genetics, biology, chemistry, etc.) • 2-5 years of post-graduate school professional experience, including at least 2 years of relevant experience in the life sciences sector (e.g., l